View Item 

Show simple item record

Wnt signaling in triple-negative breast cancer

dc.contributor.authorPohl, S.
dc.contributor.authorBrook, N.
dc.contributor.authorAgostino, Mark
dc.contributor.authorArfuso, Frank
dc.contributor.authorKumar, Alan Prem
dc.contributor.authorDharmarajan, Arunasalam
dc.date.accessioned2017-04-28T13:57:52Z
dc.date.available2017-04-28T13:57:52Z
dc.date.created2017-04-28T09:06:12Z
dc.date.issued2017
dc.identifier.citationPohl, S. and Brook, N. and Agostino, M. and Arfuso, F. and Kumar, A.P. and Dharmarajan, A. 2017. Wnt signaling in triple-negative breast cancer. Oncogenesis. 6: e310.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/52196
dc.identifier.doi10.1038/oncsis.2017.14
dc.description.abstract

Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregulation in canonical and non-canonical Wnt signaling. In this review, we summarize regulators of canonical and non-canonical Wnt signaling, as well as Wnt signaling dysfunction that mediates the progression of TNBC. We review the complex molecular nature of TNBC and the emerging therapies that are currently under investigation for the treatment of this disease.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleWnt signaling in triple-negative breast cancer
dc.typeJournal Article
dcterms.source.volume6
dcterms.source.number4
dcterms.source.issn2157-9024
dcterms.source.titleOncogenesis
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusOpen access


Files in this item

Thumbnail
Name:
251660.pdf
Size:
3.038Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/